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The HTATIP gene consists of 14 exons. 7,586 bases. 
Transcription 
The predominant mRNA transcribed from this gene is 
2,229 bp long. This is actually the isoform 2 of 
HTATIP. 
Two others isoforms generated by alternative splicing 
have been described:  
- Isoform 1 retains the alternatively spliced intro 1, 
- Isoform 3 lacks exon 5. 
Pseudogene 
No pseudogene is currently known. 
Protein 
Description 
The Tip60 protein (isoform 2) is 513 amino acids long 
and its molecular weight is about 60 kDa. It was cloned 
and characterized in 1996 thanks to its interaction with 
the HIV-1 transactivator Tat protein. 
Isoform 1 produces a 546 amino acids long protein. 
Isoform 3 produces a 461 amino acids long protein. 
A novel isoform, Tip55, encodes a novel splicing 
variant corresponding to 103 amino acids of the C-
terminus. 
The domain architectures of human TIP60 is similar to 
yeast Esa1 protein and consist of a chromodomain and 
a MYST domain harboring a zinc finger and an Acetyl-
CoA binding site. 
Expression 
Tip60 is ubiquitously expressed. 
In mouse adult tissues Tip60 is expressed in the 
following decreasing order of intensity: testis, heart, 
brain, kidney, liver, lung, with little to no expression in 
spleen and skeletal muscle. 
In human, Tip60 (Isoform 2) and PLIP (Isoform 3) are 
expressed in human heart, kidney and brain tissue. 
With a half-life of approximately 30 minutes, Tip60 is 
very unstable. In normal conditions, the proteasome 
pathway permits to maintain low protein levels. Tip60 
is ubiquitinated and targeted to proteasome-mediated 
degradation by Mdm2 but also by p300-associated E4 
ubiquitin ligase. Tip60 is stabilized after DNA damge, 
and accumulates in cells. Moreover, Tip60 is the target 
of several post-translational modifications such as 
phosphorylation on serine 86 and 90 by cdc2 but also
acetylation by p300/CBP acetyltransferases.  
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Acetylation by p300/CBP occurs in the zinc finger of 
Tip60 but consequences of this modification are 
currently not known. Finally, a recent report shows that 
Tip60 is sumoylated at lysines 430 and 451 via Ubc9.  
No data are available about regulation of the Tip60 
promoter. 
Localisation 
Tip60 (Isoform 2) is nuclear. PLIP (Isoform 3) is 
nuclear but also cytoplasmic. 
Function 
Tip60 is a Histone Acetyltransferase (HAT), which 
belongs to the MYST family. It participates in a 
multimolecular complex: The Tip60 complex, which 
contains proteins such as p400, Tip49a and Tip49b. 
Within this complex, Tip60 exerts its HAT activity on 
nucleosomal histone H4. Tip60 is involved in various 
cellular mechanisms:  
In transcription: Tip60 acts as a coactivator. Indeed, 
Tip60 is able to interact with transcription factors, such 
as E2F-1 or c-Myc. Tip60 can be recruited to Myc and
E2F-1 target promoters and enhances Myc 
transactivation. It also acetylates histone H4 on several 
E2F responsive genes. Moreover Tip60 was found to 
be involved in nuclear receptor (NR) signaling and to 
be a NR-coregulator. 
In apoptosis and cell cycle arrest: Tip60 can interact 
with and acetylate the tumor suppressor p53. It 
enhances p53 binding to pro-apoptotic target genes lik  
PUMA, Bax or Fas. Moreover, Tip60 is also required 
for cell growth arrest via the p21-dependent pathway. 
In DNA repair: Tip60 is involved in double strand 
breaks (DSB) repair. Interacting and acetylating ATM, 
Tip60 participates in DNA damage signaling. But, 
Tip60 is also involved directly in DSB repair since it is 
recruited, with TRRAP, to the DSB site. Tip60 
interacts with the chromatin surrounding sites of DSBs 
and this recruitment is responsible for hyperacetylation 
of histone H4. 
Homology 
Tip60 CHROMO domain has been identified by 
sequence homology with the Heterochromatin-
associated protein 1 (HP1) chromodomain, which 
recognizes methylated lysines. It also harbors the 
MYST domain, which is highly conserved from yeast 
to human. 
Homologs in other species:  
- S. Cerevisae: Esa1 
- D. Melanogaster: DmeI/Tip60 
- M. musculus: Htatip 
- R. norvegicus: Htatip  
Predicted:  
- P.troglodytes: HTATIP 
- M. mulatta: HTATIP 
Mutations 
Note: No mutation in Tip60 protein has been currently 
described. 
Implicated in 
Acquired Immunodeficiency Syndrome 
(AIDS) 
Disease 
Tip60 interacts with the HIV-1 transactivator Tat and 
this interaction inhibits Tip60 HAT activity. Moreover, 
in Jurkat cells, Tat enhances Tip60 turnover since it 
uses the p300/CBP-associated E4-type ubiquitin-ligase 
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activity to induce polyubiquitynation and degradation 
of Tip60. This targeting by Tat induces an impairment 




In the nucleus of human H4 neuroglioma cells, TIP60 
can interact with a free carboxyl-terminal intracellular 
fragment, APP-CT, which is generated by the cleavage 
of the Amyloid precursor protein APP by a gamma-
secretase. This fragment induces apoptosis of 
neuroglioma and this cell death is enhanced when a 
wild type form of Tip60 is transfected. Thus Tip60 
might play a role in Alzheimer’s disease 
neurodegeneration. 
Spinocerebellar ataxia type-1 
Disease 
TIP60 participates in a complex with ATXN1 and 
ROR-alpha in a conditional transgenic mouse model of 
Spinocerebellar ataxia type-1 (SCA1), one of the nine 




Immunohistochemistry experiments have shown that 
Tip60 accumulates in the nucleus of hormone-
refractory prostate cancer compared to prostate 
hyperplasia and primary prostate cancer. 
Lung cancer and colon cancer 
Disease 
Real time RT-PCR experiments have shown that Tip60 




The expression levels of TIP60 protein, analyzed by 
western blot, were found to be greater in skin tumors as 
compared to adjacent non-tumor-bearing skin in a skin
cancer mouse model (K6/ODC mouse). Additionally, 
the interaction between Tip60 and E2F1 is enhanced in 
these tumors. 
HTLV-1 induced leukemogenesis 
Disease 
Enhancement of c-Myc transforming activity by 
HTLV-1 p30II oncoprotein in HeLa cells requires 
TIP60 HAT activity. 
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